Table of Content

1 Industrial Chain Overview

• 1.1 Chemotherapy-Induced Nausea and Vomiting Drugs Industry
  • 1.1.1 Overview
  • 1.1.2 Characteristics of Chemotherapy-Induced Nausea and Vomiting Drugs
• 1.2 Upstream
  • 1.2.1 Major Materials
  • 1.2.2 Manufacturing Overview
• 1.3 Product List By Type
  • 1.3.1 Existing Drugs
  • 1.3.2 Akynzeo (Netupitant-Palonosetron FDC)
  • 1.3.3 Aloxi (Palonosetron)
  • 1.3.4 Emend (Aprepitant)
  • 1.3.5 Kytril Generic (Granisetron)
  • 1.3.6 Zofran Generic (Ondansetron)
  • 1.3.7 Pipeline Drugs
  • 1.3.8 SUSTOL (Granisetron Injection extended release)
  • 1.3.9 Rolapitant
• 1.4 End-Use List
  • 1.4.1 Demand in Serotonin Receptor Antagonists
  • 1.4.2 Demand in NK1 Receptor Antagonists
• 1.5 Global Market Overview
  • 1.5.1 Global Market Size and Forecast, 2015-2025
  • 1.5.2 Global Market Size and Forecast by Geography with CAGR, 2015-2025
  • 1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2015-2025
  • 1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2015-2025

2 Global Production & Consumption by Geography

• 2.1 Global Production & Consumption
  • 2.1.1 Global Production
  • 2.1.2 Global Consumption
• 2.2 Geographic Production & Consumption
  • 2.2.1 Production
    • 2.2.1.1 Asia-Pacific
    • 2.2.1.2 North America
    • 2.2.1.3 South America
    • 2.2.1.4 Europe
    • 2.2.1.5 Middle East & Africa
  • 2.2.2 Consumption
    • 2.2.2.1 Asia-Pacific
    • 2.2.2.2 North America
    • 2.2.2.3 South America
    • 2.2.2.4 Europe
    • 2.2.2.5 Middle East & Africa

  3 Major Manufacturers Introduction

  • 3.1 Manufacturers Overview
  • 3.2 Manufacturers List
    • 3.2.1 Merck & Co., Inc. Overview
      • 3.2.1.1 Product Specifications
      • 3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.1.3 Recent Developments
      • 3.2.1.4 Future Strategic Planning
    • 3.2.2 GlaxoSmithKline plc Overview
      • 3.2.2.1 Product Specifications
      • 3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.2.3 Recent Developments
      • 3.2.2.4 Future Strategic Planning
    • 3.2.3 Tesaro, Inc. Overview
      • 3.2.3.1 Product Specifications
      • 3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.3.3 Recent Developments
      • 3.2.3.4 Future Strategic Planning
    • 3.2.4 Helsinn Group Overview
      • 3.2.4.1 Product Specifications
      • 3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.4.3 Recent Developments
      • 3.2.4.4 Future Strategic Planning
    • 3.2.5 F. Hoffmann-La Roche Ltd. Overview
      • 3.2.5.1 Product Specifications
      • 3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.5.3 Recent Developments
      • 3.2.5.4 Future Strategic Planning
    • 3.2.6 Heron Therapeutics, Inc. Overview
      • 3.2.6.1 Product Specifications
      • 3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.6.3 Recent Developments
      • 3.2.6.4 Future Strategic Planning
    • 3.2.7 Dr. Reddy's Laboratories Ltd. Overview
      • 3.2.7.1 Product Specifications
      • 3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.7.3 Recent Developments
      • 3.2.7.4 Future Strategic Planning
    • 3.2.8 Acacia Pharma Overview
      • 3.2.8.1 Product Specifications
      • 3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.8.3 Recent Developments
      • 3.2.8.4 Future Strategic Planning
    • 3.2.9 Sun Pharmaceutical Industry Ltd. Overview
      • 3.2.9.1 Product Specifications
      • 3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.9.3 Recent Developments
      • 3.2.9.4 Future Strategic Planning
    • 3.2.10 Otsuka Holdings Co., Ltd. Overview
      • 3.2.10.1 Product Specifications
      • 3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.10.3 Recent Developments
      • 3.2.10.4 Future Strategic Planning

    4 Market Competition Pattern

    • 4.1 Market Size and Sketch
    • 4.2 Company Market Share
      • 4.2.1 Global Production by Major Manufacturers
      • 4.2.2 Market Concentration Analysis
    • 4.3 Market News and Trend
      • 4.3.1 Merger & Acquisition
      • 4.3.2 New Product Launch

    5 Product Type Segment

    • 5.1 Global Overview by Product Type Segment
    • 5.2 Segment Subdivision by Product Type
      • 5.2.1 Market in Existing Drugs
        • 5.2.1.1 Market Size
        • 5.2.1.2 Situation & Development
      • 5.2.2 Market in Akynzeo (Netupitant-Palonosetron FDC)
        • 5.2.2.1 Market Size
        • 5.2.2.2 Situation & Development
      • 5.2.3 Market in Aloxi (Palonosetron)
        • 5.2.3.1 Market Size
        • 5.2.3.2 Situation & Development
      • 5.2.4 Market in Emend (Aprepitant)
        • 5.2.4.1 Market Size
        • 5.2.4.2 Situation & Development
      • 5.2.5 Market in Kytril Generic (Granisetron)
        • 5.2.5.1 Market Size
        • 5.2.5.2 Situation & Development
      • 5.2.6 Market in Zofran Generic (Ondansetron)
        • 5.2.6.1 Market Size
        • 5.2.6.2 Situation & Development
      • 5.2.7 Market in Pipeline Drugs
        • 5.2.7.1 Market Size
        • 5.2.7.2 Situation & Development
      • 5.2.8 Market in SUSTOL (Granisetron Injection extended release)
        • 5.2.8.1 Market Size
        • 5.2.8.2 Situation & Development
      • 5.2.9 Market in Rolapitant
        • 5.2.9.1 Market Size
        • 5.2.9.2 Situation & Development

      6 End-Use Segment

      • 6.1 Global Overview by End-Use Segment
      • 6.2 Segment Subdivision
        • 6.2.1 Market in Serotonin Receptor Antagonists
          • 6.2.1.1 Market Size
          • 6.2.1.2 Situation & Development
        • 6.2.2 Market in NK1 Receptor Antagonists
          • 6.2.2.1 Market Size
          • 6.2.2.2 Situation & Development

        7 Market Forecast & Trend

        • 7.1 Regional Forecast
        • 7.2 Consumption Forecast
          • 7.2.1 Product Type Forecast
          • 7.2.2 End-Use Forecast
        • 7.3 Investment Trend
        • 7.4 Consumption Trend

        8 Price & Channel

        • 8.1 Price and Cost
          • 8.1.1 Price
          • 8.1.2 Cost
        • 8.2 Channel Segment

        9 Market Drivers & Investment Environment

        • 9.1 Market Drivers
        • 9.2 Investment Environment

        10 Research Conclusion

        List of Tables

        Table Global Market Size and Forecast by Geography with Growth Rate, 2015-2025

        Table Global Market Size and Forecast by Type with Growth Rate, 2015-2025

        Table Global Market Size and Forecast by End-Use with Growth Rate, 2015-2025

        Table Global Production Volume Status and Growth Rate by Geography, 2015-2018, in Volume

        Table Global Production Amount Status and Growth Rate by Geography, 2015-2018, in Million USD

        Table Global Market Volume and Growth Rate by Geography, 2015-2018, in Volume

        Table Global Market Amount and Growth Rate by Geography, 2015-2018, in Million USD

        Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

        Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

        Table North America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

        Table North America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

        Table South America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

        Table South America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

        Table Europe Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

        Table Europe Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

        Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

        Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

        Table Asia-Pacific Market Volume and Growth Rate by Region, 2015-2018, in Volume

        Table Asia-Pacific Market Amount and Growth Rate by Region, 2015-2018, in Million USD

        Table North America Market Volume and Growth Rate by Region, 2015-2018, in Volume

        Table North America Market Amount and Growth Rate by Region, 2015-2018, in Million USD

        Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume

        Table South America Market Amount and Growth Rate by Region, 2015-2018, in Million USD

        Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume

        Table Europe Market Amount and Growth Rate by Region, 2015-2018, in Million USD

        Table Middle East & Africa Market Volume and Growth Rate by Region, 2015-2018, in Volume

        Table Middle East & Africa Market Amount and Growth Rate by Region, 2015-2018, in Million USD

        Table Major Manufacturers Headquarters and Contact Information

        Table Major Manufacturers Capacity List in 2018

        Table Merck & Co., Inc. Overview List

        Table Chemotherapy-Induced Nausea and Vomiting Drugs Business Operation of Merck & Co., Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table GlaxoSmithKline plc Overview List

        Table Chemotherapy-Induced Nausea and Vomiting Drugs Business Operation of GlaxoSmithKline plc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Tesaro, Inc. Overview List

        Table Chemotherapy-Induced Nausea and Vomiting Drugs Business Operation of Tesaro, Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Helsinn Group Overview List

        Table Chemotherapy-Induced Nausea and Vomiting Drugs Business Operation of Helsinn Group (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table F. Hoffmann-La Roche Ltd. Overview List

        Table Chemotherapy-Induced Nausea and Vomiting Drugs Business Operation of F. Hoffmann-La Roche Ltd. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Heron Therapeutics, Inc. Overview List

        Table Chemotherapy-Induced Nausea and Vomiting Drugs Business Operation of Heron Therapeutics, Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Dr. Reddy's Laboratories Ltd. Overview List

        Table Chemotherapy-Induced Nausea and Vomiting Drugs Business Operation of Dr. Reddy's Laboratories Ltd. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Acacia Pharma Overview List

        Table Chemotherapy-Induced Nausea and Vomiting Drugs Business Operation of Acacia Pharma (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Sun Pharmaceutical Industry Ltd. Overview List

        Table Chemotherapy-Induced Nausea and Vomiting Drugs Business Operation of Sun Pharmaceutical Industry Ltd. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Otsuka Holdings Co., Ltd. Overview List

        Table Chemotherapy-Induced Nausea and Vomiting Drugs Business Operation of Otsuka Holdings Co., Ltd. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Global Production Volume List by Manufacturers, 2015-2018, in Volume

        Table Global Production Volume Share List by Manufacturers, 2015-2018, in Volume

        Table Global Production Amount List by Manufacturers, 2015-2018, in Million USD

        Table Global Production Amount Share List by Manufacturers, 2015-2018, in Million USD

        Table Global Market Status and Growth Rate by Product Type Segment, 2015-2018, in Million USD

        Table Global Market Status and Growth Rate by Product Type Segment 2015-2018, in Volume

        Table Global Market Status and Growth Rate by End-Use Segment, 2015-2018, in Million USD

        Table Global Market Status and Growth Rate by End-Use Segment 2015-2018, in Volume

        Table Global Market Forecast by Region Segment 2019-2025, in Million USD

        Table Global Market Forecast by Region Segment 2019-2025, in Volume

        Table Global Market Amount by Product Type Segment 2019-2025, in Million USD

        Table Global Market Volume by Product Type Segment 2019-2025, in Volume

        Table Global Market Amount by End-Use Segment 2019-2025, in Million USD

        Table Global Market Volume by End-Use Segment 2019-2025, in Volume

        List of Figures

        Figure Chemotherapy-Induced Nausea and Vomiting Drugs Picture List

        Figure Global Market Size and Forecast with Growth Rate, 2015-2025

        Figure Global Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure Global Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure Global Market Volume and Growth Rate, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure Asia-Pacific Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure Asia-Pacific Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure North America Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure North America Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure South America Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure South America Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure Europe Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure Europe Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure Middle East & Africa Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure Middle East & Africa Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure Asia-Pacific Market Volume and Growth Rate, 2015-2018, in Volume

        Figure Asia-Pacific Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure North America Market Volume and Growth Rate, 2015-2018, in Volume

        Figure North America Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume

        Figure South America Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume

        Figure Europe Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure Middle East & Africa Market Volume and Growth Rate, 2015-2018, in Volume

        Figure Middle East & Africa Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure Global Production Volume Share by Manufacturers in 2019, in Volume

        Figure Global Production Amount Share by Manufacturers in 2019, in Million USD

        Figure Global Market Amount and Growth Rate in Existing Drugs, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Existing Drugs, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Akynzeo (Netupitant-Palonosetron FDC), 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Akynzeo (Netupitant-Palonosetron FDC), 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Aloxi (Palonosetron), 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Aloxi (Palonosetron), 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Emend (Aprepitant), 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Emend (Aprepitant), 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Kytril Generic (Granisetron), 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Kytril Generic (Granisetron), 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Zofran Generic (Ondansetron), 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Zofran Generic (Ondansetron), 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Pipeline Drugs, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Pipeline Drugs, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in SUSTOL (Granisetron Injection extended release), 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in SUSTOL (Granisetron Injection extended release), 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Rolapitant, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Rolapitant, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Serotonin Receptor Antagonists, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Serotonin Receptor Antagonists, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in NK1 Receptor Antagonists, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in NK1 Receptor Antagonists, 2015-2018, in Volume

According to 99Strategy, the Global Chemotherapy-Induced Nausea and Vomiting Drugs Market is estimated to reach xxx million USD in 2019 and projected to grow at the CAGR of xx% during the 2020-2025. The report analyses the global Chemotherapy-Induced Nausea and Vomiting Drugs market, the market size and growth, as well as the major market participants.
The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Key Regions
Asia Pacific
North America
Europe
South America
Middle East & Africa
Key Companies
Merck & Co., Inc.
GlaxoSmithKline plc
Tesaro, Inc.
Helsinn Group
F. Hoffmann-La Roche Ltd.
Heron Therapeutics, Inc.
Dr. Reddy's Laboratories Ltd.
Acacia Pharma
Sun Pharmaceutical Industry Ltd.
Otsuka Holdings Co., Ltd.
Key Product Type
Existing Drugs
Akynzeo (Netupitant-Palonosetron FDC)
Aloxi (Palonosetron)
Emend (Aprepitant)
Kytril Generic (Granisetron)
Zofran Generic (Ondansetron)
Pipeline Drugs
SUSTOL (Granisetron Injection extended release)
Rolapitant
Market by Application
Serotonin Receptor Antagonists
NK1 Receptor Antagonists
Main Aspects covered in the Report
Overview of the Chemotherapy-Induced Nausea and Vomiting Drugs market including production, consumption, status & forecast and market growth
2015-2018 historical data and 2019-2025 market forecast
Geographical analysis including major countries
Overview the product type market including development
Overview the end-user market including development